6505--Montelukast Chewable Tablets
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA) National Acquisition Center intends to issue a Request for Proposal (RFP) for an unrestricted procurement of Montelukast Sodium Chewable Tablets. This opportunity, identified as RFP #36E79726R0012, aims to secure an uninterrupted supply for the VA (including Consolidated Mail Order Pharmacies (CMOPs) and State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The solicitation is expected to be issued on or about February 17, 2026, with a tentative closing date of March 3, 2026.
Scope of Work
The successful contractor will provide Montelukast Sodium Chewable Tablets in various package sizes and estimated annual usages:
- Montelukast NA 4MG Tab, Chew (Unit of Use): 30-count (estimated 2,625 bottles annually), 90-count (estimated 5,988 bottles annually)
- Montelukast NA 5MG Tab, Chew (Unit of Use): 30-count (estimated 4,532 bottles annually), 90-count (estimated 15,887 bottles annually)
- Montelukast NA 5MG Tab, Chew: 1000-count (estimated 202 bottles annually)
Offerors must state the exact drug name as it appears on the label and provide a unique NDC number. The successful offeror's label with its unique NDC shall be the only label on the product; contractors shall not affix their label over another label.
Contract Details
- Contract Type: Single award contract.
- Duration: One base year plus four pre-priced one-year option periods.
- Distribution: Through the VA's and DoD's respective Pharmaceutical Prime Vendor Programs.
- Set-Aside: Unrestricted procurement.
Solicitation & Submission
- RFP Number: 36E79726R0012
- Issuance Date: On or about February 17, 2026
- Closing Date: Tentatively March 3, 2026, 2:30 PM Central Time, Chicago, USA
- Format: Electronically issued in commercial item format in accordance with FAR Part 12.
- Submission: All responsible sources may submit an offer.
- Updates: Interested offerors must continuously check SAM.gov for any future amendments and miscellaneous documents.
Point of Contact
For questions, contact Matthew Poulin, Contract Specialist, at Matthew.Poulin@va.gov or 708-786-5186.
Additional Information
- NAICS Code: 325412 (Pharmaceutical Preparation Manufacturing)
- Product Service Code: 6505 (Drugs And Biologicals)